• Users Online: 114
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 3  |  Issue : 1  |  Page : 47-56

Disease-modifying antirheumatic drugs – Old and new: A brief overview

Department of General Medicine, Amrita Institute of Medical Sciences, Kochi, Kerala, India

Correspondence Address:
Raghuveer S Prabhu
Department of Medical Oncology and Hematology, Amrita Institute of Medical Sciences, Ponekkara, Kochi - 682 041, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/CDR.CDR_50_18

Rights and Permissions

Rheumatological disorders comprise a vast subset of conditions with differing manifestations but overlap in pathogenesis. Disease-modifying antirheumatic drugs (DMARDs) are a diverse group of medications which aim at the various pathogenic factors leading to these disorders. DMARDs are of three broad subtypes: the conventional synthetic DMARDs, the biologicals, and Janus kinase inhibitors. Here, we give a brief overview of the various DMARDs with an emphasis on their practical use.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded356    
    Comments [Add]    

Recommend this journal